FinTrust Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $497K | Sell |
803
-15
| -2% | -$9.28K | 0.08% | 182 |
|
|
2024
Q2 | $452K | Buy |
818
+100
| +14% | +$55.3K | 0.08% | 177 |
|
|
2024
Q1 | $417K | Sell |
718
-429
| -37% | -$249K | 0.08% | 190 |
|
|
2023
Q4 | $609K | Sell |
1,147
-211
| -16% | -$112K | 0.12% | 153 |
|
|
2023
Q3 | $687K | Sell |
1,358
-72
| -5% | -$36.4K | 0.15% | 139 |
|
|
2023
Q2 | $787K | Hold |
1,430
| – | – | 0.19% | 127 |
|
|
2023
Q1 | $787K | Hold |
1,430
| – | – | 0.19% | 123 |
|
|
2022
Q4 | $787K | Sell |
1,430
-122
| -8% | -$67.2K | 0.19% | 123 |
|
|
2022
Q3 | $814K | Buy |
1,552
+10
| +0.6% | +$5.25K | 0.21% | 114 |
|
|
2022
Q2 | $866K | Buy |
1,542
+50
| +3% | +$28.1K | 0.22% | 112 |
|
|
2022
Q1 | $881K | Buy |
1,492
+153
| +11% | +$90.3K | 0.2% | 111 |
|
|
2021
Q4 | $893K | Buy |
1,339
+167
| +14% | +$111K | 0.21% | 104 |
|
|
2021
Q3 | $670K | Buy |
1,172
+170
| +17% | +$97.2K | 0.18% | 114 |
|
|
2021
Q2 | $505K | Buy |
1,002
+14
| +1% | +$7.06K | 0.13% | 139 |
|
|
2021
Q1 | $451K | Hold |
988
| – | – | 0.13% | 142 |
|
|
2020
Q4 | $460K | Sell |
988
-325
| -25% | -$151K | 0.15% | 131 |
|
|
2020
Q3 | $580 | Buy |
1,313
+944
| +256% | +$417 | 0.11% | 96 |
|
|
2020
Q2 | $134K | Sell |
369
-58
| -14% | -$21.1K | 0.05% | 281 |
|
|
2020
Q1 | $121K | Sell |
427
-4
| -0.9% | -$1.13K | 0.06% | 257 |
|
|
2019
Q4 | $140K | Sell |
431
-35
| -8% | -$11.4K | 0.06% | 278 |
|
|
2019
Q3 | $136K | Buy |
466
+50
| +12% | +$14.6K | 0.05% | 272 |
|
|
2019
Q2 | $122K | Buy |
416
+233
| +127% | +$68.3K | 0.05% | 267 |
|
|
2019
Q1 | $50K | Sell |
183
-185
| -50% | -$50.5K | 0.02% | 393 |
|
|
2018
Q4 | $82K | Buy |
+368
| New | +$82K | 0.04% | 286 |
|